Srikala Sridhar

14PUBLICATIONS
136CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersTe hauora me te oranga ā-whaea, ā-pēpi o te Māori (Māori mothers and babies health and wellbeing)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|May 16, 2026
TROPION-Urothelial03: a phase II/III study of datopotamab deruxtecan (Dato-DXd) for locally advanced or metastatic urothelial carcinoma.

|Feb 27, 2026
Prospective multicenter study of ctDNA versus tumor tissue guiding FGFR-targeted therapy in metastatic urothelial cancer.

David C Müller, Andrew J Murtha, Jack V W Bacon

|Dec 13, 2025
Advanced Urologic Cancer Consensus Conference (AUC3) 2025: Expert consensus on the management of renal cell and urinary tract cancers.

Rana R McKay, Sumanta Pal, Wanling Xie

|Jul 29, 2025
Blood-Epigenetic Biomarker Associations with Tumor Immunophenotype in Patients with Urothelial Carcinoma from JAVELIN Bladder 100.

Thomas Powles, Srikala S Sridhar, Joaquim Bellmunt

|Apr 17, 2025
On the Horizon: A Global Multidisciplinary Perspective on Delivering Emerging Therapies for Patients with BCG-Naïve High-Risk NMIBC.

Bernadett E Szabados, Félix Guerrero-Ramos, Enrique Grande

|Feb 13, 2025
Split-Dose Cisplatin Use, Eligibility Criteria, and Drivers for Treatment Choice in Patients with Locally Advanced or Metastatic Urothelial Carcinoma: Results of a Large International Physician Survey.

Richard O'Dwyer, Sophia Junker, Robert Szulkin

Pageof 3

Frequent Collaborators

4 joint publications

Petros Grivas

3 joint publications

Eric Winquist

3 joint publications

Thomas Powles

2 joint publications

Bradley McGregor